Literature DB >> 7027528

A randomized, placebo controlled trial of prostacyclin (PGI2) in peripheral arterial disease.

V Hossman, A Heinen, H Auel, G A FitzGerald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7027528     DOI： 10.1016/0049-3848(81)90109-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  6 in total

1.  Antiplatelet effects of intravenous iloprost in patients with peripheral arterial obliterative disease. A placebo-controlled dose-response study.

Authors:  H Darius; V Hossmann; K Schrör
Journal:  Klin Wochenschr       Date:  1986-06-16

2.  Prostaglandin therapy in severe limb ischemia.

Authors:  B J Pardy; H H Eastcott
Journal:  World J Surg       Date:  1983-05       Impact factor: 3.352

Review 3.  Prostaglandins, thromboxanes and leukotrienes in clinical medicine.

Authors:  R D Zipser; G Laffi
Journal:  West J Med       Date:  1985-10

Review 4.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

5.  Stability of prostacyclin analogues: an unusual lack of reactivity in acid-catalyzed alkene hydration.

Authors:  A Magill; C O'Yang; M F Powell
Journal:  Pharm Res       Date:  1988-04       Impact factor: 4.200

6.  Prolonged infusion of prostacyclin in patients with advanced stages of peripheral vascular disease: a placebo-controlled cross-over study.

Authors:  V Hossmann; H Auel; W Rücker; K Schrör
Journal:  Klin Wochenschr       Date:  1984-12-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.